Class information for:
Level 1: POLYCYSTIC OVARY SYNDROME//PCOS//HYPERANDROGENISM

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
88 4356 42.9 83%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
612 13263 POLYCYSTIC OVARY SYNDROME//PCOS//HYPERANDROGENISM

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 POLYCYSTIC OVARY SYNDROME Author keyword 1161 55% 33% 1455
2 PCOS Author keyword 372 48% 13% 563
3 HYPERANDROGENISM Author keyword 191 48% 7% 288
4 POLYCYSTIC OVARIAN SYNDROME Author keyword 82 41% 4% 155
5 HIRSUTISM Author keyword 78 35% 4% 183
6 POLYCYSTIC OVARIES Author keyword 56 46% 2% 92
7 HYPERANDROGENEMIA Author keyword 51 53% 2% 68
8 METFORMIN Author keyword 39 11% 8% 345
9 POLYCYSTIC OVARY SYNDROME PCOS Author keyword 39 50% 1% 55
10 ANDROGEN EXCESS Author keyword 30 54% 1% 38

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class		 LCSH search Wikipedia search
1 POLYCYSTIC OVARY SYNDROME 1161 55% 33% 1455 Search POLYCYSTIC+OVARY+SYNDROME Search POLYCYSTIC+OVARY+SYNDROME
2 PCOS 372 48% 13% 563 Search PCOS Search PCOS
3 HYPERANDROGENISM 191 48% 7% 288 Search HYPERANDROGENISM Search HYPERANDROGENISM
4 POLYCYSTIC OVARIAN SYNDROME 82 41% 4% 155 Search POLYCYSTIC+OVARIAN+SYNDROME Search POLYCYSTIC+OVARIAN+SYNDROME
5 HIRSUTISM 78 35% 4% 183 Search HIRSUTISM Search HIRSUTISM
6 POLYCYSTIC OVARIES 56 46% 2% 92 Search POLYCYSTIC+OVARIES Search POLYCYSTIC+OVARIES
7 HYPERANDROGENEMIA 51 53% 2% 68 Search HYPERANDROGENEMIA Search HYPERANDROGENEMIA
8 METFORMIN 39 11% 8% 345 Search METFORMIN Search METFORMIN
9 POLYCYSTIC OVARY SYNDROME PCOS 39 50% 1% 55 Search POLYCYSTIC+OVARY+SYNDROME+PCOS Search POLYCYSTIC+OVARY+SYNDROME+PCOS
10 ANDROGEN EXCESS 30 54% 1% 38 Search ANDROGEN+EXCESS Search ANDROGEN+EXCESS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SYNDROME PCOS 406 71% 8% 327
2 HYPERANDROGENISM 247 47% 9% 389
3 ANDROGEN EXCESS 235 63% 5% 238
4 PCOS 232 67% 5% 209
5 GRADE CHRONIC INFLAMMATION 169 84% 2% 93
6 HYPERANDROGENIC WOMEN 159 68% 3% 138
7 NORMAL MENSES 147 89% 2% 66
8 ESTRADIOL CYPROTERONE ACETATE 134 87% 2% 66
9 P450C17 ALPHA ACTIVITY 114 86% 1% 57
10 POLYCYSTIC OVARY SYNDROME 106 15% 15% 668

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis 2011 198 205 80%
Metabolic risk in PCOS: phenotype and adiposity impact 2015 2 64 92%
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report 2009 364 246 52%
Medical progress: Polycystic ovary syndrome 2005 718 124 81%
Polycystic ovary syndrome 2007 337 157 78%
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis 2010 164 109 80%
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan 2010 128 70 89%
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications 2012 110 519 55%
PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis 2011 77 22 91%
Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis 2014 16 38 63%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ENDOCRINOL HUMAN REPROD 22 41% 0.9% 41
2 ANDROGEN RELATED DISORDERS 21 75% 0.3% 15
3 DIABET OBES HUMAN REPROD GRP 14 60% 0.3% 15
4 FISIOPATOL OVAR 11 67% 0.2% 10
5 CHOLESTEROL 8 25% 0.7% 29
6 DIABET VASC MED UNIT 8 45% 0.3% 13
7 GYNECOL ENDOCRINOL UNIT 7 26% 0.6% 24
8 JEAN HAILES CLIN UNIT 7 67% 0.1% 6
9 ENDOCRINE SECT INTERNAL MED 1 6 80% 0.1% 4
10 REPROD FERTIL 6 80% 0.1% 4

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000199357 HIRSUTISM//IDIOPATHIC HIRSUTISM//3 ALPHA ANDROSTANEDIOL GLUCURONIDE
2 0.0000142464 CLOMIPHENE CITRATE//LAPAROSCOPIC OVARIAN DRILLING//LAPAROSCOPIC OVARIAN DIATHERMY
3 0.0000137289 SHBG GENE POLYMORPHISM//CLIN MED CHEM MED//ENDOCRINE SECT INTERNAL MED 3
4 0.0000086509 MALE OBESITY//MAINE BARIATR SURG PROGRAM//FEMALE OBESITY
5 0.0000073862 DISTURBED DAILY RHYTHM//TIANZHU WHITE YAK//ANIM ANAT TISSUE EMBRYOL
6 0.0000068696 GONADOTROPHIC CELLS//SOMATOTROPIC CELLS//GONADOTROPIC CELLS
7 0.0000063240 OVARIAN RESERVE//ANTI MULLERIAN HORMONE//ANTRAL FOLLICLE COUNT
8 0.0000058632 17 ALPHA HYDROXYLASE 17 20 LYASE DEFICIENCY//17 ALPHA HYDROXYLASE DEFICIENCY//ADRENARCHE
9 0.0000051352 LELAND J DOROTHY H OLSON WOMENS HLTH//NEBRASKA MED 984515//3 ISOBUTYL 1 METHYL XANTHINE IBMX
10 0.0000041051 ENDOMETRIAL THICKNESS//THIN ENDOMETRIUM//FOLLICULAR VASCULARITY